Long-Term Follow-Up Results for NRG/RTOG 0815: A Phase III Prospective Randomized Trial of Dose-Escalated Radiotherapy With or Without Short-Term Androgen Deprivation Therapy for Patients With Intermediate-Risk Prostate Cancer

Authors

• Daniel J. Krauss, Corewell Health East
• T G. Karrison
• A A. Martinez
• G Morton
• D W. Bruner
• M A. Elshaikh
• D Yan
• B Movsas
• D E. Citrin
• A Jani

Document Type

Conference Proceeding

Publication Date

9-2026

Publication Title

International Journal of Radiation Oncology, Biology, Physics

Volume

126

Issue

1 Suppl

First Page

S44

Last Page

S45

Recommended Citation

Krauss DJ, Karrison TG, Martinez AA, Morton G, Bruner DW, Elshaikh MA, et al. Long-term follow-up results for NRG/RTOG 0815: a phase III prospective randomized trial of dose-escalated radiotherapy with or without short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer. Int J Radiat Oncol Biol Phys. 2026 Sep;126(1 Suppl):S44-S45. doi:10.1016/j.ijrobp.2026.06.019

Comments

American Society for Radiation Oncology (ASTRO) 68th Annual Meeting, September 26-30, 2026, Boston, MA

DOI

10.1016/j.ijrobp.2026.06.019